Healthcare [ 12/13 ] | Medical Devices [ 109/164 ]
NASDAQ | Common Stock
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours.
The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 9, 24 | 0.73 Increased by +217.39% | 0.39 Increased by +87.18% |
| Feb 22, 24 | 1.40 Increased by +483.33% | 0.66 Increased by +112.12% |
| Nov 2, 23 | 0.71 Increased by +102.86% | 0.40 Increased by +77.50% |
| Aug 8, 23 | 0.38 Increased by +176.00% | 0.26 Increased by +46.15% |
| May 4, 23 | 0.23 Decreased by -42.50% | 0.11 Increased by +109.09% |
| Feb 23, 23 | 0.24 Decreased by -42.86% | 0.21 Increased by +14.29% |
| Nov 3, 22 | 0.35 Increased by +94.44% | 0.15 Increased by +133.33% |
| Aug 4, 22 | -0.50 Decreased by -317.39% | 0.22 Decreased by -327.27% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 441.70 M Increased by +23.35% | 51.50 M Increased by +116.39% | Increased by +11.66% Increased by +75.43% |
| Dec 31, 23 | 509.80 M Increased by +37.90% | 103.30 M Increased by +507.65% | Increased by +20.26% Increased by +340.66% |
| Sep 30, 23 | 432.70 M Increased by +26.97% | 51.90 M Increased by +1.10 K% | Increased by +11.99% Increased by +886.10% |
| Jun 30, 23 | 396.50 M Increased by +32.43% | 27.30 M Increased by +178.00% | Increased by +6.89% Increased by +158.90% |
| Mar 31, 23 | 358.10 M Increased by +21.23% | 23.80 M Decreased by -14.39% | Increased by +6.65% Decreased by -29.38% |
| Dec 31, 22 | 369.70 M Increased by +20.15% | 17.00 M Decreased by -41.78% | Increased by +4.60% Decreased by -51.54% |
| Sep 30, 22 | 340.80 M Increased by +23.66% | -5.20 M Decreased by -141.27% | Decreased by -1.53% Decreased by -133.37% |
| Jun 30, 22 | 299.40 M Increased by +13.75% | -35.00 M Decreased by -40.00% | Decreased by -11.69% Decreased by -23.07% |